Abstract:To appraise the efficacy of Acarbose at lunch in treatment of type 2 diabetes with inadequate glycemic control after lunch treated with Insulin Lispro Mix25 before breakfast and supper. Methods Eighty-six cases with type 2 diabetes mellitus, who were treated with Insulin Lispro Mix25 Injection before breakfast and supper but still had inadequate glycemic control after lunch (> 10 mmol/L), were randomly divided into two groups. The patients in the group A were added with Acarbose 50-100 mg at lunch to improve post-prandial blood glucose. The patients in the group B were added with Insulin Lispro Mix25 Injection 0.1-0.3 u/kg before lunch to improve postprandial blood glucose. After 2 weeks, the changes of seven-point blood glucose spectrum (before three meals, 2 h after three meals, at bedtime) and the frequency of hypoglycemia were compared between the two groups. Results The rate of the patients reaching the standard level of postprandial 2-h blood glucose after lunch was not significantly different between the group A and the group B (86.05%vs 88.37%, p> 0.05). Comparison of the seven-point blood glucose spectra of the two groups showed that the postprandial 2-h blood glucose after supper in the group B was significantly lower than that in the group A[(6.1 ±1.1) mmol/L vs (7.8 ±1.0) mmol/L,p < 0.05], while the blood glucose levels at other time points were not different between the two groups. The frequency of hypoglycemia in the group A was significantly lower than that in the group B (4.65% vs 18.60%,p <0.05). Conclusions Application of Acarbose at lunch can effectively control the postprandial 2-h blood glucose after lunch, and decrease the frequency of hypoglycemia.